Hi, what are you looking for?
Jewish Business News
Search results for "Teva Pharmaceutical"
Business
Reuters Exclusive: Generics drugmaker Mylan NV (MYL.O), which is in the middle of a three-way takeover battle, has said it is unwilling to...
Business
John Paulson's hedge fund has increased its holdings in Mylan NV to 4.5%.
Leadership & A-List
The Teva shareholder and digital printing pioneer thinks Teva should be investing in innovation, not cheap commodity drugs.
Business
[FULL LETTER] After Mylan Responded aggressively to Teva's bid, Erez Vigodman says in an open letter to Robert Coury: Shareholders won't benefit from Mud...
Business
Julius Baer analyst Lilian Montero insists it's illogical for Mylan to remain independent.
Court
Tamir Capital is invested in Proneuron, which successfully sued Teva for abuse of a license for its product.
Business
Board concludes that approach grossly undervalues Mylan, includes Teva stock, and would expose Mylan to a problematic culture and leadership with poor record of...
Business
Teva CEO Erez Vigodman bypasses Mylan's board and appeals directly to its shareholders.
Business
Generic drugmaker Mylan (MYL) said on Friday it would take its $31 billion offer for Perrigo Co Plc directly to shareholders, in what is...
Business
Bloomberg reports that Teva is working with Barclays Bank on a takeover bid for Mylan.